IN THE SPOTLIGHT

Computational exploration of novel indanone-pyrazole fused schiff base scaffolds as potential EGFR inhibitors for anticancer therapy

Computational exploration of novel indanone-pyrazole fused schiff base scaffolds as potential EGFR inhibitors for anticancer therapy

Targeting ABCA3 impedes tumor progression and EGFR-TKI resistance in EGFR-mutant LUAD

Targeting ABCA3 impedes tumor progression and EGFR-TKI resistance in EGFR-mutant LUAD

Dr Felip on Treating EGFR-Mutated NSCLC and Supporting Trial Data

Dr Felip on Treating EGFR-Mutated NSCLC and Supporting Trial Data

Updated incidence of EGFR mutation in Middle Eastern patients with non-small cell lung cancer: a 7-year study in a Lebanese institution

Updated incidence of EGFR mutation in Middle Eastern patients with non-small cell lung cancer: a 7-year study in a Lebanese institution

Impact of eGFR estimation methods on drug dosing in pediatric ICU: a study of serum creatinine vs. cystatin C

Impact of eGFR estimation methods on drug dosing in pediatric ICU: a study of serum creatinine vs. cystatin C

ARTS Trial: Adjuvant Aumolertinib in Resected EGFR-Mutated NSCLC

ARTS Trial: Adjuvant Aumolertinib in Resected EGFR-Mutated NSCLC